Hepatorenal Syndrome Analysis and Forecast Report 2025-2035: Market Led by Mallinckrodt, Noorik, BioVie, and Ferring as Innovation, Partnerships, and Market Expansion Drive Competitive Gro...
Medtronic plc. Ordinary Shares (MDT)
Last medtronic plc. ordinary shares earnings: 2/18 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investorrelations.medtronic.com
Company Research
Source: Yahoo! Finance
Characterized by two types, HRS-AKI and HRS-CKD, it demands urgent treatment due to high mortality rates. Increasing liver disease prevalence, spurred by lifestyle factors, is driving the HRS market. However, high treatment costs and organ donor shortages pose challenges. Market leaders, such as Mallinckrodt and Ferring, focus on innovation, partnerships, and expanding into regions like Asia-Pacific to address these issues effectively. Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hepatorenal Syndrome Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global hepatorenal syndrome market is highly competitive, with several key players driving innovation and market growth. Leading companies such as Mallinckrodt Pharmaceuticals, Noorik Biopharmaceuticals, BioVie Inc., and Ferring Pharmaceuticals are at the forefront of the market, each contributing through innovative
Show less
Read more
Impact Snapshot
Event Time:
MDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDT alerts
High impacting Medtronic plc. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDT
News
- Medtronic plc declares $0.71 dividend [Seeking Alpha]Seeking Alpha
- Medtronic announces cash dividend for third quarter of fiscal year 2026PR Newswire
- Medtronic gets FDA clearance of Hugo robotic-assisted surgery system [Seeking Alpha]Seeking Alpha
- Medtronic (NYSE:MDT) had its "buy (b)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical proceduresPR Newswire
MDT
Earnings
- 11/18/25 - Beat
MDT
Sec Filings
- 12/3/25 - Form SCHEDULE
- 11/25/25 - Form 10-Q
- 11/25/25 - Form IRANNOTICE
- MDT's page on the SEC website